Stock FGEN FIBROGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features FibroGen, Inc.

Equities

FGEN

US31572Q8087

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.04 USD +1.96% Intraday chart for FibroGen, Inc. -9.57% +17.34%
Apr. 24 FibroGen, Inc. to Present Clinical Data from Dose Escalation Phase 1B Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer at 2024 American Society of Clinical Oncology Annual Meeting CI
Apr. 15 Faron Pharmaceuticals reappoints former finance chief on interim basis AN

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Analyst recommendations: Hewlett Packard, Apple, Tesla, Mosaic, Rite Aid...Analyst recommendations: Hewlett Packard, Apple, Tesla, Mosaic, Rite Aid... August 30, 2023 at 12:24 pm EDT
Investors cheer on bad dataInvestors cheer on bad data August 30, 2023 at 09:47 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FGEN Stock
  4. News FibroGen, Inc.
  5. MarketScreener Editorial Features